BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12798539)

  • 1. A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality.
    Dickinson JE; Evans SF
    Obstet Gynecol; 2003 Jun; 101(6):1294-9. PubMed ID: 12798539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination.
    Dickinson JE; Evans SF
    Am J Obstet Gynecol; 2002 Mar; 186(3):470-4. PubMed ID: 11904609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial.
    Dickinson JE; Jennings BG; Doherty DA
    Obstet Gynecol; 2014 Jun; 123(6):1162-1168. PubMed ID: 24807339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination.
    Feldman DM; Borgida AF; Rodis JF; Leo MV; Campbell WA
    Am J Obstet Gynecol; 2003 Sep; 189(3):710-3. PubMed ID: 14526299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y; Chanrachakul B; Punyavachira P
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal versus oral misoprostol for second-trimester pregnancy termination: a randomized trial.
    Behrashi M; Mahdian M
    Pak J Biol Sci; 2008 Nov; 11(21):2505-8. PubMed ID: 19205272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination.
    Jain JK; Kuo J; Mishell DR
    Obstet Gynecol; 1999 Apr; 93(4):571-5. PubMed ID: 10214835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination.
    Bebbington MW; Kent N; Lim K; Gagnon A; Delisle MF; Tessier F; Wilson RD
    Am J Obstet Gynecol; 2002 Oct; 187(4):853-7. PubMed ID: 12388963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised trial of two regimens of vaginal misoprostol to manage termination of pregnancy of up to 16 weeks.
    Khazardoost S; Hantoushzadeh S; Madani MM
    Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):226-9. PubMed ID: 17550491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy.
    Ngai SW; Tang OS; Ho PC
    Hum Reprod; 2000 Oct; 15(10):2205-8. PubMed ID: 11006200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of 3 misoprostol protocols for abortion induction at 13-20 weeks of gestation.
    Caliskan E; Dilbaz S; Doger E; Ozeren S; Dilbaz B
    J Reprod Med; 2005 Mar; 50(3):173-80. PubMed ID: 15841929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination.
    Guix C; Palacio M; Figueras F; Bennasar M; Zamora L; Coll O; Cararach V
    Fetal Diagn Ther; 2005; 20(6):544-8. PubMed ID: 16260893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases.
    Ashok PW; Templeton A
    Br J Obstet Gynaecol; 1999 Jul; 106(7):706-10. PubMed ID: 10428528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK; Mukherji J; Kamilya GS; Ray S; Hazra A
    Acta Obstet Gynecol Scand; 2006; 85(12):1458-62. PubMed ID: 17260222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial.
    Wong KS; Ngai CS; Yeo EL; Tang LC; Ho PC
    Hum Reprod; 2000 Mar; 15(3):709-12. PubMed ID: 10686224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent low-dose misoprostol for termination of second-trimester pregnancy.
    Dilbaz S; Caliskan E; Dilbaz B; Kahraman BG
    Eur J Contracept Reprod Health Care; 2004 Mar; 9(1):11-5. PubMed ID: 15352690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8 and 16 weeks of gestation].
    Qian J; Jing X; Wu S; Zheng S; Li Y; Ren M; Di W; Shen H; Dong B; Chang Q; Shi H; Yao C; Song W; Huang Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):505-9. PubMed ID: 26311640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.